Get the Stockscreener App
0.18
4.76%
-0.009
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Prophase Labs Inc stock is traded at $0.18, with a volume of 1.38M.
It is down -4.76% in the last 24 hours and down -53.42% over the past month.
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
See More
Previous Close:
$0.189
Open:
$0.198
24h Volume:
1.38M
Relative Volume:
0.72
Market Cap:
$8.31M
Revenue:
$7.33M
Net Income/Loss:
$-21.20M
P/E Ratio:
-0.1969
EPS:
-0.9143
Net Cash Flow:
$-12.68M
1W Performance:
-32.05%
1M Performance:
-53.42%
6M Performance:
-43.82%
1Y Performance:
-76.59%
1-Day Range:
$0.1754
$0.20
1-Week Range:
$0.1754
$0.2858
52-Week Range:
$0.1754
$0.9349
Prophase Labs Inc Stock (PRPH) Company Profile
Name
Prophase Labs Inc
Sector
Industry
Phone
(215) 345-0919
Address
711 STEWART AVE, SUITE 200, NEW YORK, PA
Compare PRPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.18 | 7.85M | 7.33M | -21.20M | -12.68M | -0.9143 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-13-21 | Downgrade | Dawson James | Buy → Neutral |
| Jan-20-21 | Initiated | Dawson James | Buy |
Prophase Labs Inc Stock (PRPH) Latest News
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2025 Earnings Call Transcript - MSN
ProPhase Labs signals $50M net collection target and strategic initiatives as Crown Medical litigation advances - MSN
Is ProPhase Labs Inc. stock vulnerable to regulatory risksForecast Cut & Advanced Technical Analysis Signals - newser.com
Reversal indicators forming on ProPhase Labs Inc. stock2025 Key Highlights & AI Forecast for Swing Trade Picks - newser.com
ProPhase Labs Reports Q3 Loss Amid Strategic Shifts - TipRanks
Earnings call transcript: ProPhase Labs Q3 2025 posts unexpected EPS loss - Investing.com Nigeria
ProPhase Labs’ Earnings Call: Challenges and Opportunities - The Globe and Mail
What data driven models say about ProPhase Labs Inc.’s future - newser.com
ProPhase Labs Q3 2025 Earnings Call Transcript - MarketBeat
[10-Q] ProPhase Labs, Inc. Quarterly Earnings Report | PRPH SEC FilingForm 10-Q - Stock Titan
ProPhase Labs in talks for strategic initiative, cites undervalued assets By Investing.com - Investing.com Nigeria
ProPhase Labs, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:PRPH) 2025-11-19 - Seeking Alpha
Prophase Labs Unveils Strategic Initiatives and Partnerships - MSN
ProPhase Labs, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2025 - MarketScreener
ProPhase Labs earnings missed by $0.05, revenue fell short of estimates - Investing.com Canada
ProPhase Labs reported results for the third quarter ended September 30, 2025, and will hold a virtual conference call today at 2pm ET. - MarketScreener
ProPhase Labs (PRPH) Explores Strategic M&A Opportunities - GuruFocus
ProPhase Labs (PRPH) Q3 Revenue Decline but Future Prospects Bri - GuruFocus
[8-K] ProPhase Labs, Inc. Reports Material Event | PRPH SEC FilingForm 8-K - Stock Titan
ProPhase Labs Reported Results for the Third Quarter Ended September 30, 2025, and Will Hold a Virtual Conference Call Today at 2pm ET. - The Manila Times
ProPhase Labs in talks for strategic initiative, cites undervalued assets - Investing.com
ProPhase Labs Explores Strategic Initiatives to Unlock Company Value Amidst Key Developments in Crown Medical and BE-Smart™ Commercialization - Quiver Quantitative
ProPhase Labs Reported Results for the Third Quarter Ended - GlobeNewswire
ProPhase Labs (NASDAQ: PRPH) Targets $50M Crown Medical Recoveries to Fund BE-Smart - Stock Titan
How ProPhase Labs Inc. stock reacts to job market dataTrade Exit Summary & AI Powered Buy/Sell Recommendations - newser.com
A Peek at ProPhase Labs's Future Earnings - Benzinga
ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19 - The Manila Times
Starwood Property Trust (NYSE: STWD) Plans $500M 2028 Notes for Green, Social Uses - Stock Titan
Why analysts upgrade ProPhase Labs Inc. stockJuly 2025 EndofMonth & Reliable Volume Spike Alerts - newser.com
ProPhase Labs reminds shareholders of upcoming special meeting By Investing.com - Investing.com Nigeria
ProPhase Labs Inc. stock chart pattern explainedJuly 2025 Recap & Daily Price Action Insights - newser.com
ProPhase Labs (PRPH) Announces Special Meeting to Shape Future S - GuruFocus
ProPhase Labs reminds shareholders of upcoming special meeting - Investing.com
ProPhase Labs Urges Shareholders to Vote by November 23 on Proxy Proposals - The Manila Times
ProPhase Labs urges shareholders to vote by November 23 on proxy proposals - MarketScreener
Prophase Labs Urges Shareholders To Vote By November 23 On Proxy Proposals - TradingView
ProPhase Labs (NASDAQ: PRPH) urges shareholder votes by Nov. 23 for Nov. 24 meeting - Stock Titan
Using data tools to time your ProPhase Labs Inc. exitMarket Sentiment Review & Weekly Hot Stock Watchlists - newser.com
Can ProPhase Labs Inc. stock beat analyst upgradesJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - newser.com
Can machine learning forecast ProPhase Labs Inc. recovery2025 Investor Takeaways & Verified Momentum Stock Alerts - newser.com
ProPhase Labs Delays Q3 Filing Amid Reorganization - MSN
What moving averages say about ProPhase Labs Inc.July 2025 Volume & Expert Approved Momentum Ideas - newser.com
Prophase Labs Inc Stock (PRPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):